Supplementary Figure 5 from Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High &lt;i&gt;EGFR&lt;/i&gt; Gene Copy Number